Life Science REIT Dividends and Buybacks
Dividend criteria checks 3/6
Life Science REIT is a dividend paying company with a current yield of 5.21% that is well covered by earnings.
Key information
5.2%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | 6.5% |
Dividend Growth | 34.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | €0.020 |
Payout ratio | 59% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: JL6 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: JL6's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
Life Science REIT Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (JL6) | 5.2% |
Market Bottom 25% (DE) | 0% |
Market Top 25% (DE) | 0% |
Industry Average (Health Care REITs) | 0% |
Analyst forecast (JL6) (up to 3 years) | 6.5% |
Notable Dividend: JL6's dividend (5.21%) is higher than the bottom 25% of dividend payers in the German market (1.74%).
High Dividend: JL6's dividend (5.21%) is in the top 25% of dividend payers in the German market (4.76%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.4%), JL6's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: JL6 is paying a dividend but the company has no free cash flows.